FDA issued a Warning Letter to Hybrid Pharma, LLC on 11/30/2018 for a previous inspection.
483 Hybrid Pharma Jun 2019

483 Hybrid Pharma Jun 2019

Bonita Chester FDA$119.00 - Available Now

FDA investigators audited the Hybrid Pharma - Deerfield Beach, FL, United States facility and issued inspectional observations (via FDA 483) on 20 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Jun 2019
  • Location: Deerfield Beach, United States
  • FEI: 3011319445
Add To Cart